Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MMRvaxpro at 6 Months of Age
NCT03780179Phase 4Completed
- Sponsor
- Rigshospitalet
- Start
- Apr 2019
- Primary completion
- Jan 2022
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of M-M-R II in measles, mumps, rubella, sponsored by Rigshospitalet. Started Apr 2019; status: completed.
02
Drugs
M-M-R II
03
Conditions
measlesmumpsrubella
Beyond the preview
Go deeper on NCT03780179.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03780179.